Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Val-Cit-PAB-MMAE contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE (HY-15162)
InChiKey: DUXQKCCELUKXOE-CBBZIXHGSA-N
SCH 79797 protects against ischemia/reperfusion-induced arrhythmias in the rat hearts
NCC(=O)CCC(=O)OCC1C=CC=CC=1
Gefitinib-d3 - CAS# 1173976-40-3 Size:Contact [email protected] for quotation Val-Cit-PAB-MMAE contains the ADCs linkerGefitinib d3 (ZD1839 d3) is the deuterium labeled Gefitinib. Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity. Product information CAS Number: 1173976 40 3 Molecular
US$ 65.00
US$ 38.00
US$ 38.00
US$ 85.00
US$ 180.00
US$ 114.00
US$ 388.50
US$ 88.00
US$ 114.00
US$ 68.00
US$ 48.00